Qingdao Haier Biomedical Co Ltd (688139) - Total Liabilities

Latest as of March 2026: CN¥1.15 Billion CNY ≈ $168.81 Million USD

Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has total liabilities worth CN¥1.15 Billion CNY (≈ $168.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688139 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Qingdao Haier Biomedical Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Qingdao Haier Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688139 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Qingdao Haier Biomedical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zhongsheng Group Holdings Limited F:5Z0	Germany	€60.19 Billion
Tilaknagar Industries Limited NSE:TI	India	Rs31.78 Billion
RPC Inc NYSE:RES	USA	$384.66 Million
Hyprop JSE:HYP	South Africa	ZAC16.26 Billion
Shuangliang Eco-Energy Systems Co Ltd SHG:600481	China	CN¥20.88 Billion
Shanghai Zhezhong Construction Co Ltd SHE:002346	China	CN¥1.34 Billion
Pabrik Kertas Tjiwi Kimia Tbk JK:TKIM	Indonesia	Rp988.48 Million
Canfor Corporation TO:CFP	Canada	CA$2.43 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Qingdao Haier Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688139 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qingdao Haier Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qingdao Haier Biomedical Co Ltd (2016–2025)

The table below shows the annual total liabilities of Qingdao Haier Biomedical Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.17 Billion ≈ $170.96 Million	-0.09%
2024-12-31	CN¥1.17 Billion ≈ $171.11 Million	+7.70%
2023-12-31	CN¥1.09 Billion ≈ $158.87 Million	-19.02%
2022-12-31	CN¥1.34 Billion ≈ $196.18 Million	+6.31%
2021-12-31	CN¥1.26 Billion ≈ $184.54 Million	+8.89%
2020-12-31	CN¥1.16 Billion ≈ $169.46 Million	+99.30%
2019-12-31	CN¥581.08 Million ≈ $85.03 Million	-47.84%
2018-12-31	CN¥1.11 Billion ≈ $163.01 Million	+93.43%
2017-12-31	CN¥575.92 Million ≈ $84.28 Million	+154.31%
2016-12-31	CN¥226.46 Million ≈ $33.14 Million	--

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.31 Billion

CN¥8.92 Billion CNY

Market Cap Rank

#7759 Global

#1744 in China

Share Price

CN¥28.18

Change (1 day)

-2.08%

52-Week Range

CN¥24.70 - CN¥37.36

All Time High

CN¥147.76